4//SEC Filing
EASTLAND JULIA MARIE 4
Accession 0001725160-24-000189
CIK 0001725160other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:02 PM ET
Size
5.8 KB
Accession
0001725160-24-000189
Insider Transaction Report
Form 4
EASTLAND JULIA MARIE
DirectorCEO & President
Transactions
- Award
Stock Option (Right to Buy)
2024-12-02+3,028,800→ 3,028,800 totalExercise: $3.66Exp: 2034-12-02→ Common Stock (3,028,800 underlying)
Footnotes (1)
- [F1]The options will vest over a four-year period following the vesting commencement date of November 13, 2024, in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001500189
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:02 PM ET
- Size
- 5.8 KB